Background
Soccer is one of the most popular sports globally, and FIFA estimated a 34% increase in the number of participants between 2000 and 2011 [
1]. Soccer players require high levels of aerobic fitness to cover large distances during match play (> 10 km) [
2] while a cognitive component is also required due to decision-making during games [
3]. Team-sport-specific tests such as Yo–Yo Intermittent Recovery Test 1 (YYIR1) and 2 (YYIR2) are used to simulate competition demands and evaluate intermittent running performance changes in team-sport athletes. Krustrup et al. [
4] showed that performance in the YYIR1 test is significantly correlated (r = 0.81) with the number of high-intensity running actions performed at the end of each half of a game. The widespread use of nutritional supplements is commonplace within the sport to enhance athletic performance. While there is some evidence to support the use of selected performance supplements in specific soccer scenarios (e.g., creatine, beta-alanine, bicarbonate, caffeine, and nitrate/beetroot juice), there is a lack of information relating to the combination of these products and their combined ergogenic effects [
5].
Caffeine (CAF) is a hugely popular supplement for soccer players aiming to improve performance [
6]. Physiological responses following ingestion include increased catecholamine secretion, neuromuscular function, vigilance and alertness, and reduced perception of effort during exercise [
7]. Some studies reported an improvement in total distance covered during soccer match-play [
8], while others failed to show ergogenic effects of CAF on time to fatigue test in soccer players [
9]. Nonetheless, CAF may be an effective supplement to improve soccer-specific exercise capacity.
Nitrate-rich beetroot juice (BJ) is another popular nutritional supplement which may be of interest for soccer. Specifically, improvements in team sport-specific tests like the YYIR1 have been shown with nitrate (NO3
−) supplementation [
10,
11], though some studies reported no improvement in team-sport high-intensity efforts during sport-specific actions following BJ ingestion [
12,
13]. Mechanisms to explain these performance enhancements include increased blood flow, muscle contraction, calcium handling, and mechanical efficiency [
14,
15]. Thus, BJ may also be an effective supplement to improve soccer-specific exercise capacity.
While the ergogenic effects of BJ and CAF may be of interest for team-sports athletes, information typically results from generic protocols that are isolated from other strategies that the athletes may also be implementing. In practice, athletes tend to consume several supplements simultaneously [
5]. The combined use of supplements can occur either acutely, targeting a specific competition, or chronically throughout a training program. In this regard, previous studies have investigated the combination of BJ and CAF within a laboratory environment with contrasting results [
16‐
19]. Cognitive function is essential for athletic performance with variables such as attention, memory, and executive functions involving working memory, decision-making, and multitasking shown to be improved by CAF and BJ ingestion separately [
20,
21]. However, no studies have evaluated the combined effects of BJ and CAF on soccer-specific exercise capacity, lower limb muscular power measured by countermovement jump with arm swing (CMJAS), or cognitive performance. Given the independent beneficial effects that BJ and CAF may have on soccer-specific exercise capacity and their different physiological pathways, combining these two supplements may result in additive effects.
The current study aimed to investigate the isolated and combined effects of CAF and BJ supplementation on performance during the YYIR1, CMJAS, and cognitive function. We hypothesized that the increased CNS drive and reduced perceived exertion elicited by CAF supplementation, combined with improvements in metabolic efficiency resulting from BJ ingestion, would improve exercise capacity compared with taking each supplement in isolation or consuming a placebo (PL).
Discussion
The current study investigated BJ and CAF supplementation effects on soccer-specific exercise capacity in isolation and combination. Contrary to the hypothesis, BJ + CAF co-ingestion did not lead to superior effects compared to the ingestion of either BJ or CAF alone or in comparison to a PL condition. Moreover, supplementation of both BJ and CAF in isolation did not lead to performance improvements compared to PL.
A growing body of scientific evidence supports the ergogenic benefits of BJ supplementation during high-intensity intermittent activities. Wylie et al. [
10] showed a 4.2% improvement in YYIR1 in recreationally active soccer players after ingesting 29 mmol of NO3
− over a 30-h period compared to a PL (1704 ± 304 m vs. 1636 ± 288 m). Similarly, Thompson et al. [
34] reported a 3.4% improvement in YYIR1 performance in male team-sport players after five days of ingesting 6.4 mmol of NO3
− (1422 ± 502 vs. 1369 ± 505 m). Nyakayiru et al. [
11] also reported enhanced YYIR1 performance with BJ compared to a PL (+ 3.4%) in trained soccer players after six days of ingesting 12.9 mmol of NO3
−. In contrast, our study showed that acute ingestion of 60 ml of NO3
−-rich BJ containing 6.4 mmol of NO3
− 2.5 h before exercise did not improve YYIR1 performance in semi-professional soccer players. The training status of the participants could explain the difference between our results and others. Athletes here ran a higher distance in the test than those in previous studies [
10,
11,
34], suggesting a superior training level. Based on the previous studies suggesting BJ is less effective in more trained individuals, it is possible that individuals with a higher aerobic fitness level need a greater amount of NO3
−, perhaps via chronic supplementation, to sufficiently elevate intramuscular and plasma NO3
− to improve exercise performance [
15,
35]. Thus, an insufficient dose could explain, at least in part, the lack of an effect shown here. Furthermore, we used an acute dose of BJ that may not have been sufficient to improve exercise capacity since previous studies showed improved YYIR1 performance following chronic supplementation, even though NO3
− doses > 5 mmol ingested approximately 2.5 h prior to exercise have previously been shown to exert ergogenic effects [
15]. Furthermore, data suggest that the quantity of NO3
− found in some commercially available NO3
− products may not entirely represent the claimed values [
36,
37]. Thus, the possibility that the NO3
− supplement used had a sub-optimal quantity of NO3
− cannot be entirely excluded. Our findings suggest that well-trained male team-sport athletes may require a chronic supplementation strategy and a higher total NO3
− dose to elicit ergogenic benefits, especially compared to that in recreational athletes [
38], although this remains to be experimentally tested.
Caffeine is a popular ergogenic aid used extensively by team-sport athletes in doses ranging from 3 to 6 mg/kg BM [
39]. However, equivocal findings are available concerning the efficacy of CAF administration on YYIR1 performance [
40‐
42]. Ellis et al. [
43] showed no improvement in YYIR1 performance in elite male soccer players following the ingestion of 1–3 mg/kg BM of CAF, and the authors suggested that a higher dose may be required to elicit performance gains. However, the present study does not support this suggestion since there was no significant improvement in YYIR1 performance following ingestion of 5 mg/kg BM of CAF in semi-professional soccer players. Therefore, the current findings add to the body of evidence indicating no clear benefit of CAF on YYIR1 performance. A recent meta-analysis by Grgic et al. [
44] suggested that CAF improves YYIR2 performance, which may be due to the increased anaerobic system contribution. Inter-individual factors such as genotype variation, training status, and CAF tolerance have also been suggested to modify the erogenicity of CAF [
45] and may have contributed to the results, although these factors were not explored in the current study.
This is the first study that investigated whether co-ingestion of BJ + CAF would be more effective than the ingestion of BJ or CAF alone during team-sport-specific exercise. In this regard, we hypothesized that the combination of these two supplements would be synergistic due to distinct, but potentially complementary, mechanisms. BJ was proposed to enhance the contractile function of type II muscle fibers and improve high-intensity intermittent performance [
46]. Complementary to this, CAF could improve exercise capacity via its influence on the central nervous system which could delay fatigue [
47]. However, the findings demonstrated no improvement during the YYIR1 test following combined- compared to single-supplement ingestion or PL. Effect sizes suggest that the co-ingestion of BJ and CAF led to a minimal increase in performance compared to CAF alone and compared to PL. Such an improvement may be worthwhile for soccer players, although confidence intervals were wide. Therefore, co-ingestion of these ergogenic aids before training and competition may be worth trialing on an individual basis. Finally, the lack of ergogenicity seen in these supplementation strategies may be related to external factors such as nutritional status (both acute and chronic), sleep pattern, physical activity level, training status, and small sample size [
48]. Overall, this finding agrees with previous studies that reported no significant effects of combining BJ + CAF on maximal and submaximal running [
19] or cycling [
16‐
18].
There was moderate evidence for a higher HRav with CAF alone compared to PL, but not with the addition of BJ to CAF. This may be due to CAF ingestion's effects on the autonomic nervous system by increasing catecholamine secretion, which consequently increases HR [
39], while the vasodilatory effects of BJ may eliminate this effect. RPE increased throughout the YYIR1 protocol but was not influenced by supplementation. This is in contrast to substantial data showing reduced RPE with CAF supplementation [
49]. It is unclear why there was no effect in our study. In the current study, some participants reported low to moderate GI distress following BJ + CAF supplementation. The exact cause is unclear, and more studies are needed to confirm the safety and side-effects associated with BJ + CAF co-ingestion.
We showed no effect of supplementation on CMJAS jump height or power output. This result contrasts with a previous study that reported increased CMJ height after CAF supplementation [
50,
51]. Previous studies reported no ergogenic effect of BJ on CMJ of professional tennis players or basketball players at the dose employed in this study (6.4 mmol of NO3
−) [
12,
13]. Although different studies have reported a reduced CMJ performance post-exercise that have proposed the diminution of height reached post-exercise as an indicator of neuromuscular fatigue [
52,
53]; a trend to a higher height on CMJ has been found in this study. In this case, the higher jumps recorded post-YYIR1 could be related to post-activation performance enhancement during exercise running protocol that means the level of muscle potentiation is greater than neuromuscular fatigue associated with running exercise [
54]. Furthermore, CMJ is considered a good indicator of lower limb muscular power, and additional transference of upper limb force can induce a greater jump height during the execution of a CMJAS, where the arms are involved [
29]. This transference of force is dependent on good coordination to transfer angular moments between the different body segments. The effect of BJ supplementation may be less pronounced when the movement becomes more complex and involves more moving parts, although this hypothesis remains to be tested.
Cognitive ability, which plays an important role in team sports performance, includes the action of perception, learning, decision-making, and communication, and is sensitive to changes in physical demand, mood, and arousal [
55]. At very high-intensity exercise (85%V̇O
2peak) cognitive function deteriorates with a clear detrimental effect on reaction time [
56]. Team sports players are generally required to make rapid and appropriate decisions whilst simultaneously exercising at variable intensities. There was an increase in correct responses during the Stroop test recorded post-YYIR1, consistent with previous studies suggesting that high-intensity intermittent exercise may benefit cognitive function [
57]. While these benefits are well known, the mechanisms by which they occur are unclear [
57]. However, supplementation with BJ and/or CAF showed no significant cognitive function effect pre-or post-exercise. These findings agree with previous studies that have investigated the isolated effects of BJ [
58] or CAF [
59].
This study has some limitations. It was not possible to measure blood NO3
−, nitrite, or CAF concentrations, and the absence of these measurements might be considered the main limitation of the study. Similarly, we could not quantify the amount of NO3
− in the supplement provided, which may be more variable than claimed [
37]. Furthermore, we did not perform a sample size calculation and chose to recruit a sample of convenience, which means our study might have been underpowered to detect small effects from supplementation protocols [
60]. Also, blinding efficacy was not determined here; supplement identification could influence exercise outcomes and is a potential source of bias in sports nutrition [
61]. The dosing strategy used here (an acute and low dose of BJ) is another possible limitation and it cannot be ruled out that greater or more chronic doses might lead to different results. Future research should consider these limitations to provide more insight into the co-ingestion of these ergogenic aids during team sport-specific performance.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.